|
1
|
Lingvay I, Pérez Manghi F,
García-Hernández P, Norwood P, Lehmann L, Tarp-Johansen MJ and Buse
JB: DUAL V Investigators: Effect of insulin glargine up-titration
vs insulin degludec/liraglutide on glycated hemoglobin levels in
patients with uncontrolled type 2 diabetes: The DUAL V randomized
clinical trial. JAMA. 315:898–907. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pfeffer MA, Claggett B, Diaz R, Dickstein
K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, et
al: Lixisenatide in patients with type 2 diabetes and acute
coronary syndrome. N Engl J Med. 373:2247–2257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bader M: ACE2, angiotensin-(1–7), and mas:
The other side of the coin. Pflugers Arch. 465:79–85. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamming I, Cooper ME, Haagmans BL, Hooper
NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G and van
Goor H: The emerging role of ACE2 in physiology and disease. J
Pathol. 212:1–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang LH, Pang XF, Bai F, Wang NP, Shah
AI, McKallip RJ, Li XW, Wang X and Zhao ZQ: Preservation of
glucagon-like peptide-1 level attenuates angiotensin II-induced
tissue fibrosis by altering AT1/AT 2 receptor expression and
angiotensin-converting enzyme 2 activity in rat heart. Cardiovasc
Drugs Ther. 29:243–255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tikellis C, Pickering R, Tsorotes D, Du
XJ, Kiriazis H, Nguyen-Huu TP, Head GA, Cooper ME and Thomas M:
Interaction of diabetes and ACE2 in the pathogenesis of
cardiovascular disease in experimental diabetes. Clin Sci (Lond).
123:519–529. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zygalaki E, Kaklamanis L, Nikolaou NI,
Kyrzopoulos S, Houri M, Kyriakides Z, Lianidou ES and Kremastinos
DT: Expression profile of total VEGF, VEGF splice variants and VEGF
receptors in the myocardium and arterial vasculature of diabetic
and non-diabetic patients with coronary artery disease. Clin
Biochem. 41:82–87. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jesmin S, Zaedi S, Shimojo N, Iemitsu M,
Masuzawa K, Yamaguchi N, Mowa CN, Maeda S, Hattori Y and Miyauchi
T: Endothelin antagonism normalizes VEGF signaling and cardiac
function in STZ-induced diabetic rat hearts. Am J Physiol
Endocrinol Metab. 292:E1030–E1040. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chitose T, Sugiyama S, Sakamoto K,
Shimomura H, Yamashita T, Hokamaki J, Tsunoda R, Shiraishi S,
Yamashita Y and Ogawa H: Effect of a hydrophilic and a hydrophobic
statin on cardiac salvage after ST-elevated acute myocardial
infarction-a pilot study. Atherosclerosis. 237:251–258. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Muhlestein JB, Lappé DL, Lima JA, Rosen
BD, May HT, Knight S, Bluemke DA, Towner SR, Le V, Bair TL, et al:
Effect of screening for coronary artery disease using CT
angiography on mortality and cardiac events in high-risk patients
with diabetes: The FACTOR-64 randomized clinical trial. JAMA.
312:2234–2243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dombi T, Kwok KK and Sultan MB: A
retrospective, pooled data analysis of the safety of pegaptanib
sodium in the treatment of age-related macular degeneration in
subjects with or without diabetes mellitus. BMC Ophthalmol.
12:372012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li W, Zhao W, Wu Q, Lu Y, Shi J and Chen
X: Puerarin improves diabetic aorta injury by inhibiting NADPH
oxidase-derived oxidative stress in STZ-induced diabetic rats. J
Diabetes Res. 2016:85415202016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shukla R, Pandey N, Banerjee S and
Tripathi YB: Effect of extract of Pueraria tuberosa on expression
of hypoxia inducible factor-1α and vascular endothelial growth
factor in kidney of diabetic rats. Biomed Pharmacother. 93:276–285.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao Y, Wang X and He C: An
isoflavonoid-enriched extract from Pueraria lobata (kudzu) root
protects human umbilical vein endothelial cells against oxidative
stress induced apoptosis. J Ethnopharmacol. 193:524–530. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ai F, Chen M, Yu B, Yang Y, Xu G, Gui F,
Liu Z, Bai X and Chen Z: Puerarin accelerates cardiac angiogenesis
and improves cardiac function of myocardial infarction by
upregulating VEGFA, Ang-1 and Ang-2 in rats. Int J Clin Exp Med.
8:20821–20828. 2015.PubMed/NCBI
|
|
16
|
Liang J, Yin K, Cao X, Han Z, Huang Q,
Zhang L, Ma W, Ding F, Bi C, Feng D, et al: Attenuation of low
ambient temperature-induced myocardial hypertrophy by atorvastatin
via promoting Bcl-2 expression. Cell Physiol Biochem. 41:286–295.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mingrone G, Panunzi S, De Gaetano A,
Guidone C, Iaconelli A, Nanni G, Castagneto M, Bornstein S and
Rubino F: Bariatric-metabolic surgery versus conventional medical
treatment in obese patients with type 2 diabetes: 5 year follow-up
of an open-label, single-centre, randomised controlled trial.
Lancet. 386:964–973. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Derosa G, Mugellini A, Pesce RM, D'Angelo
A and Maffioli P: Barnidipine compared to lercanidipine in addition
to losartan on endothelial damage and oxidative stress parameters
in patients with hypertension and type 2 diabetes mellitus. BMC
Cardiovasc Disord. 16:662016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Strand E, Pedersen ER, Svingen GF,
Schartum-Hansen H, Rebnord EW, Bjørndal B, Seifert R, Bohov P,
Meyer K, Hiltunen JK, et al: Dietary intake of n-3 long-chain
polyunsaturated fatty acids and risk of myocardial infarction in
coronary artery disease patients with or without diabetes mellitus:
A prospective cohort study. BMC Med. 11:2162013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McMullan CJ, Lambers Heerspink HJ, Parving
HH, Dwyer JP, Forman JP and de Zeeuw D: Visit-to-visit variability
in blood pressure and kidney and cardiovascular outcomes in
patients with type 2 diabetes and nephropathy: A post hoc analysis
from the RENAAL study and the Irbesartan Diabetic Nephropathy
Trial. Am J Kidney Dis. 64:714–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jakljević T, Ruzić A, Bazdarić K,
Zaputović L, Mavrić Z, Champagne S and Teiger E: Detection of
myocardial ischemia in diabetic patients: The limitations of
myocardial perfusion imaging. Coll Antropol. 36:821–826.
2012.PubMed/NCBI
|
|
22
|
Drefs M, Thomas MN, Guba M, Angele MK,
Werner J, Conrad M, Steib CJ, Holdt LM, Andrassy J, Khandoga A and
Rentsch M: Modulation of glutathione hemostasis by inhibition of
12/15-lipoxygenase prevents ROS-mediated cell death after hepatic
ischemia and reperfusion. Oxid Med Cell Longev. 2017:83257542017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Al-Taweel AM, Raish M, Perveen S, Fawzy
GA, Ahmad A, Ansari MA, Mudassar S and Ganaie MA: Nepeta
deflersiana attenuates isoproterenol-induced myocardial injuries in
rats: Possible involvement of oxidative stress, apoptosis,
inflammation through nuclear factor (NF)-κB downregulation.
Phytomedicine. 34:67–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patel VB, Mori J, McLean BA, Basu R, Das
SK, Ramprasath T, Parajuli N, Penninger JM, Grant MB, Lopaschuk GD
and Oudit GY: ACE2 deficiency worsens epicardial adipose tissue
inflammation and cardiac dysfunction in response to diet-induced
obesity. Diabetes. 65:85–95. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iribarren C, Phelps BH, Darbinian JA,
McCluskey ER, Quesenberry CP, Hytopoulos E, Vogelman JH and
Orentreich N: Circulating angiopoietins-1 and −2, angiopoietin
receptor Tie-2 and vascular endothelial growth factor-A as
biomarkers of acute myocardial infarction: A prospective nested
case-control study. BMC Cardiovasc Disord. 11:312011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shams AS, Mohammed MH, Loka MM and Abdel
Rahman GM: Assessment of the protective role of prenatal zinc
versus insulin supplementation on fetal cardiac damage induced by
maternal diabetes in rat using caspase-3 and KI67
immunohistochemical stains. Cardiol Res Pract. 2016:74695492016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Liu Z, Wang J, Wong GT, Cheung CW,
Zhang L, Chen C, Xia Z and Irwin MG: Susceptibility to myocardial
ischemia reperfusion injury at early stage of type 1 diabetes in
rats. Cardiovasc Diabetol. 12:1332013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan J, Duan J, Wu X, Guo C, Yin Y, Zhu Y,
Hu T, Wei G, Wen A and Xi M: Total saponins from Aralia taibaiensis
protect against myocardial ischemia/reperfusion injury through AMPK
pathway. Int J Mol Med. 36:1538–1546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chu LM, Osipov RM, Robich MP, Feng J,
Sheller MR and Sellke FW: Effect of thrombin fragment (TP508) on
myocardial ischemia reperfusion injury in a model of type 1
diabetes mellitus. Circulation. 122 11 Suppl:S162–S169. 2010.
View Article : Google Scholar : PubMed/NCBI
|
